Open AccessOff-label reduced-dose apixaban does not reduce hemorrhagic risk in Taiwanese patients with nonvalvular atrial fibrillation
Author(s) -
IChih Chen,
Wei−Ting Chang,
Po-Chao Hsu,
Ya-Lan Yeh,
Syuan Zheng,
Yuanchi Huang,
Chih-Hsien Lin,
LiangMiin Tsai,
Long-Yau Lin,
Ping-Yen Liu,
Yen-Wen Liu
Publication year - 2021
Publication title -
medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.59
H-Index - 148
eISSN - 1536-5964
pISSN - 0025-7974
DOI - 10.1097/md.0000000000026272
Subject(s) - medicine , apixaban , atrial fibrillation , hazard ratio , stroke (engine) , retrospective cohort study , confidence interval , incidence (geometry) , adverse effect , warfarin , rivaroxaban , mechanical engineering , physics , optics , engineering